Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Early diagnosis and quick treatment improve life quality for FFA patients.

Botanical extracts and Minoxidil improved hair condition in a boy with a genetic disorder.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Oral minoxidil helps with hair growth but needs more research to fully understand its effectiveness and safety.

People with diabetes have a higher risk of skin infections and complications.

A 12-year-old boy's hair loss and skin issues improved significantly with medication.

Punctate follicular porokeratosis is a skin condition with specific features seen in hair follicles.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Traumatic anserine folliculosis is a skin condition caused by friction, treatable with topical cream and avoiding trauma.

A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

A rare skin condition affected only the facial hair of a 46-year-old man.